Lei Zhang, MD
Chinese Academy of Medical Science and Blood Disease Hospital · Institute of Hematology & Blood Diseases Hospital, China · Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Lei Zhang, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:30 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07063199 · Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)Institute of Hematology & Blood Diseases Hospital, China · recruiting · Immune Thrombocytopenia, Treatment · principal investigator
- Ph2NCT06838962 · Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)Institute of Hematology & Blood Diseases Hospital, China · recruiting · Immune Thrombocytopenia, Treatment · principal investigator
- Ph2NCT06799611 · An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune ThrombocytopeniaInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Immune Thrombocytopenia (ITP), Treatment · principal investigator
- Ph1/Ph2NCT06776510 · A Clinical Study of NAD in the Treatment of Immune ThrombocytopeniaInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Immune Thrombocytopenia, Treatment · principal investigator
- Ph2NCT06281327 · Avatrombopag in the Treatment of Pediatric Immune ThrombocytopeniaInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Immune Thrombocytopenia, Treatment · principal investigator
- Early Ph1NCT06238908 · Safety and Efficacy Study of NGGT003 in Hemophilia A PatientsInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Hemophilia A · principal investigator
- Ph2NCT06199089 · A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune ThrombocytopeniaInstitute of Hematology & Blood Diseases Hospital, China · active not recruiting · Immune Thrombocytopenia, Treatment · principal investigator
- Ph2NCT06168851 · Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)Institute of Hematology & Blood Diseases Hospital, China · recruiting · Immune Thrombocytopenia, Treatment · principal investigator
- Ph2/Ph3NCT06111638 · Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy DrugsShanghai Xinzhi BioMed Co., Ltd. · recruiting · Hemophilia A · study chair
- N/ANCT06107582 · Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)Institute of Hematology & Blood Diseases Hospital, China · recruiting · Primary Immune Thrombocytopenia · principal investigator
- Ph2NCT06094881 · A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)Institute of Hematology & Blood Diseases Hospital, China · recruiting · Immune Thrombocytopenia, Treatment · principal investigator
- Ph2NCT05998759 · Telitacicept for the Treatment of Connective Tissue Disease-associated ThrombocytopeniaBeijing Hospital · recruiting · Connective Tissue Diseases, Thrombocytopenia · principal investigator
- Ph2NCT05995054 · A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune ThrombocytopeniaInstitute of Hematology & Blood Diseases Hospital, China · unknown · Immune Thrombocytopenia, Treatment · principal investigator
- Ph2NCT05983952 · Anti-CD38 Antibody Treating APS With ThrombocytopeniaInstitute of Hematology & Blood Diseases Hospital, China · unknown · Antiphospholipid Syndrome, Thrombocytopenia · principal investigator
- Ph2NCT05870475 · Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PVInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Polycythemia Vera · principal investigator
- Ph1NCT05709288 · Gene Therapy for Hemophilia B Patients Aged 12-18 Years OldInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Hemophilia B · principal investigator
- Ph2NCT05694767 · A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune ThrombocytopeniaInstitute of Hematology & Blood Diseases Hospital, China · completed · Immune Thrombocytopenia, Treatment · principal investigator
- Ph1/Ph2NCT05641610 · A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B PatientsInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Hemophilia B · principal investigator
- N/ANCT05630651 · The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.Institute of Hematology & Blood Diseases Hospital, China · recruiting · Hemophilia B · principal investigator
- Ph2NCT05619926 · Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without InhibitorStaidson (Beijing) Biopharmaceuticals Co., Ltd · completed · Hemophilia · principal investigator
- Ph4NCT05583838 · A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP PtsInstitute of Hematology & Blood Diseases Hospital, China · completed · Previously Treated Primary Immune Thrombocytopenia · principal investigator
- N/ANCT05523128 · The Efficacy and Safety of ZS802 in Chinese Hemophilia A Patients.Institute of Hematology & Blood Diseases Hospital, China · unknown · Hemophilia A · principal investigator
- Early Ph1NCT05454774 · A Study of FVIII Gene Therapy for Hemophilia AInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Hemophilia A · study chair
- Ph2NCT05395507 · Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential ThrombocythemiaInstitute of Hematology & Blood Diseases Hospital, China · unknown · Essential Thrombocytopenia · principal investigator
- Ph2NCT05236582 · Herombopag for Chemotherapy-induced ThrombocytopeniaInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Chemotherapy-induced Thrombocytopenia, Herombopag · principal investigator
- Ph2NCT05218226 · Avatrombopag for Chemotherapy-induced ThrombocytopeniaInstitute of Hematology & Blood Diseases Hospital, China · unknown · Chemotherapy-induced Thrombocytopenia, Avatrombopag · principal investigator
- Ph2NCT05214391 · A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune ThrombocytopeniaInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Immune Thrombocytopenia, Treatment · principal investigator
- Ph2/Ph3NCT05203679 · Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy DrugShanghai Xinzhi BioMed Co., Ltd. · active not recruiting · Hemophilia B · study chair
- Ph2NCT05199909 · Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary ThrombocytopeniaInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Antiphospholipid Syndrome, Thrombocytopenia, Treatment · principal investigator
- Ph2/Ph3NCT04915482 · TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With AutoantibodiesInstitute of Hematology & Blood Diseases Hospital, China · unknown · Immune Thrombocytopenia (ITP), Autoantibodies, Evan Syndrome · principal investigator
- N/ANCT04728841 · Gene Therapy for Chinese Hemophilia AInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Hemophilia A, Gene Therapy · principal investigator
- Ph2NCT04226950 · Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential ThrombocythemiaInstitute of Hematology & Blood Diseases Hospital, China · unknown · Essential Thrombocytopenia · principal investigator
- N/ANCT04135300 · Gene Therapy for Chinese Hemophilia BInstitute of Hematology & Blood Diseases Hospital, China · completed · Hemophilia B · principal investigator
- N/ANCT04014166 · Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune ThrombocytopeniaInstitute of Hematology & Blood Diseases Hospital, China · completed · Thrombocytopenia, Mesenchymal Stem Cells · principal investigator
- N/ANCT03998059 · Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia PatientsInstitute of Hematology & Blood Diseases Hospital, China · unknown · Thrombocytopenia, Splenectomy · principal investigator
- Ph2NCT03664518 · to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV InfectionInstitute of Hematology & Blood Diseases Hospital, China · completed · Thrombocytopenia Purpura, Chronic HBV Infection · principal investigator
- Ph4NCT03384277 · Trial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With RituximabInstitute of Hematology & Blood Diseases Hospital, China · completed · Acquired Hemophilia A · principal investigator
- Ph1NCT02343536 · A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed LymphomaCelgene · completed · Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular · study director
- Ph2NCT00737529 · A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" TrialCelgene · completed · Mantle Cell Lymphoma · study director
- Ph2NCT00413036 · A Study of Revlimid in the Treatment of Non-Hodgkin's LymphomaCelgene · completed · Lymphoma, Non-Hodgkin's · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:30 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.